Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bavarian Nordic ADR
(OP:
BVNRY
)
10.40
+0.02 (+0.21%)
Streaming Delayed Price
Updated: 2:13 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bavarian Nordic ADR
< Previous
1
2
3
Next >
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
September 17, 2024
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.
Via
Benzinga
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.
Via
Benzinga
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
September 06, 2024
The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval.
Via
Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
August 26, 2024
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.
Via
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
August 19, 2022
Via
Benzinga
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
August 20, 2024
GeoVax Labs has seen its shares rise enormously over the past few days after an announcement from the World Health Organization relevant to one of its drugs.
Via
MarketBeat
Exposures
COVID-19
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge
August 19, 2024
Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains.
Via
Talk Markets
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
August 19, 2024
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed.
Via
Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
August 16, 2024
Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox...
Via
Benzinga
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
August 15, 2024
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.
Via
Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus.
Via
Benzinga
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data
June 20, 2023
Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in
Via
Benzinga
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
May 18, 2023
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023
May 15, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023
May 09, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
February 15, 2023
Via
Benzinga
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
February 15, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
December 15, 2022
Via
Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
November 03, 2022
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via
Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
August 26, 2022
Via
Benzinga
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
August 25, 2022
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world....
Via
Benzinga
3 Top Monkeypox Stocks to Buy Right Now
August 24, 2022
With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.
Via
InvestorPlace
PTON Stock Pops as Peloton Products Launch on Amazon
August 24, 2022
Peloton (PTON) stock is getting a boost on Wednesday after the fitness company's products started selling on Amazon (AMZN).
Via
InvestorPlace
BVNRY Stock Alert: What to Know as Bavarian Nordic Signs Supply Agreement
August 24, 2022
Bavarian Nordic (BVNRY) stock is on the move Wednesday after the monkeypox vaccine company signed a supply agreement with PAHO.
Via
InvestorPlace
Benzinga Before The Bell: Top Amazon Seller Succumbs To Economic Meltdown, Twitter To Tackle Toxic Content, Spam Bots, Bed Bath & Beyond Secures Loan Deal As It Tries To Stay Afloat And Other Top Financial Stories Wednesday, August 24
August 24, 2022
CNBC Top Amazon Seller Succumbs To Economic Meltdown
Via
Benzinga
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
August 24, 2022
Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year.
Via
Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
August 23, 2022
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.
Via
Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
August 19, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.